Rock Creek Pharmaceuticals Inc RCPIQ:OTCPK

RT Quote | Exchange | USD
Last | 3:53 PM EST
0.006quote price arrow down-0.0011 (-15.493%)
Volume
1,841,094
52 week range
0.00 - 0.01

...

Loading . . .

KEY STATS

  • Open0.0065
  • Day High0.0079
  • Day Low0.006
  • Prev Close0.0071
  • 52 Week High0.01
  • 52 Week High Date02/10/21
  • 52 Week Low0.00
  • 52 Week Low Date05/04/20
  • Market Cap1.02M
  • Shares Out170.44M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta3.45
  • 1 Year % Change1,233.33

RATIOS/PROFITABILITY

  • EPS (TTM)-0.78
  • P/E (TTM)-0.01
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-8.74M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-116.21%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Rock Creek Pharmaceuticals Inc News

There is no recent news for this security.

Latest RCPIQ News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Rock Creek Pharmaceuticals, Inc. is a pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. The Company's activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin...
Michael Mullan Ph.D. M.D.
Chairman
William McMahon
Chief Financial Officer
Address
2040 Whitfield Ave Ste 300
Sarasota, FL
34243-3956
United States